Medical Services Advisory Committee
Page last updated: 14 July 2017
1372.1 - MRI for patients with colorectal carcinoma (CRC) with suspected hepatic metastases or patients with suspected hepatocellular carcinoma (HCC) for the purposes of staging
1376.1 - 70 gene signature (MammaPrint) for use in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit
1455 - Proton Beam Therapy for patients supported under the Medical Treatment Overseas Program
1464 - Breast Magnetic Resonance Imaging for improved definition of the breast cancer primary
1466 - Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration
1467 - Obstetric MRI
1468 - SIR-Spheres for the treatment of hepatic metastases, and other indications not listed on the MBS
1473 - A 50 gene signature assay for predicting breast cancer recurrence
1475 - Ablative fractional laser resurfacing for burn scar treatment
1476 - Genetic testing for childhood syndromes
1483 - Micro-bypass stenting for open-angle glaucoma
1496 - Micro-bypass stenting for open-angle glaucoma (external to Schlemm's canal)
Comments will be used to improve web content and will not be responded to.
This form uses a CAPTCHA to ensure that it is submitted by a person, instead of a machine or automated software.
Thank you for taking the time to provide feedback. It will be used to make improvements to this website.
© Commonwealth of AustraliaABN: 83 605 426 759